Castells X, et al. “Efficacy of Central Nervous System Stimulant Treatment for Cocaine Dependence: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials,” Addiction (Dec. 2007): Vol. 102, No. 12, pp. 1871–87. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18031423

Deng SX, et al. “Covalent Modification of Proteins by Cocaine,” Proceedings of the National Academy of Sciences (March 19, 2002): Vol. 99, No. 6, pp. 3412–16. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11891282

Heinzerling KG, et al. “Randomized, Placebo-Controlled Trial of Baclofen and Gabapentin for the Treatment of Methamphetamine Dependence,” Drug and Alcohol Dependence (Dec. 1, 2006): Vol. 85, No. 3, pp. 177–84. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16740370

Kampman KM, et al. “A Pilot Trial of Topiramate for the Treatment of Cocaine Dependence,” Drug and Alcohol Dependence (Sept. 6, 2004): Vol. 75, No. 3, pp. 233–40. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15283944

Karila L, et al. “New Treatments for Cocaine Dependence: A Focused Review,” International Journal of Neuropsychopharmacology (May 2008): Vol. 11, No. 3, pp. 425–38. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17927843

Malcolm R, et al. “Clinical Applications of Modafinil in Stimulant Abusers: Low Abuse Potential,” American Journal of Addiction (Summer 2002): Vol. 11, No. 3, pp. 247–49. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12202017

Malcolm R, et al. “The Safety of Disulfiram for the Treatment of Alcohol and Cocaine Dependence in Randomized Clinical Trials: Guidance for Clinical Practice,” Expert Opinion on Drug Safety (July 2008): Vol. 7, No. 4, pp. 459–72. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18613809

Marris E. “Immune to the High,” Nature Medicine (April 2008): Vol. 14, No. 4, pp. 358–61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18391928

Minozzi S, et al. “Anticonvulsants for Cocaine Dependence,” Cochrane Database of Systematic Reviews (2008): Art. No. CD006754. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18425968

National Institute on Drug Abuse. “Medications Development Division Nurtures the Creation of New Addiction Treatments,” NIDA Notes (July 2006): Vol. 20, No. 6, Updated July 22, 2008).

Orson FM, et al. “Substance Abuse Vaccines,” Annals of the New York Academy of Sciences (Oct. 2008): Vol. 1141, pp. 257–69. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18991962

Peterson EC, et al. “Using Hapten Design to Discover Therapeutic Monoclonal Antibodies for Treating Methamphetamine Abuse,” Journal of Pharmacology and Experimental Therapeutics (July 2007): Vol. 322, No. 1, pp. 30–39. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17452421

Reis AD, et al. “Craving Decrease with Topiramate in Outpatient Treatment for Cocaine Dependence: An Open Label Trial,” Revista Brasileira de Psiquiatria (June 2008): Vol. 30, No. 2, pp. 132–35. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18470406

Shoptaw S, et al. “Randomized Placebo-Controlled Trial of Baclofen for Cocaine Dependence: Preliminary Effects for Individuals with Chronic Patterns of Cocaine Use,” Journal of Clinical Psychiatry (Dec. 2003): Vol. 64, No. 12, pp. 1440–48. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14728105

Vocci FJ, et al. “Medication Development for Addictive Disorders: The State of the Science,” American Journal of Psychiatry (Aug. 2005): Vol. 162, No. 8, pp. 1432–40. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16055764